medigraphic.com
ISSN 1561-302X (Print)

2022, Number 1

<< Back Next >>

Rev cubana med 2022; 61 (1)

Effects of replacement therapy for subclinical hypothyroidism on carotid intima-media thick

Bernal LE, Díaz-Perera FG

Language: Spanish
References: 29
Page: 1-13
PDF size: 321.90 Kb.


ABSTRACT

Introduction: Subclinical hypothyroidism is related to cardiovascular alterations such as subclinical carotid atherosclerosis due to endothelial damage as a consequence of various factors, carotid intima-media thickness (CIMT) being a recognized marker, whose elevation is frequently mentioned in association with this thyroid dysfunction.
Objective: To determine the effects of replacement therapy in patients with subclinical hypothyroidism in CIMT.
Methods: An intervention study was carried out in 94 patients diagnosed with subclinical hypothyroidism, who did not have substitutive treatment. They were treated in Endocrinology consultation at 10 de Octubre hospital. These subjects underwent determination of TSH, total cholesterol, LDL cholesterol, cholesterol HDL, triglycerides. They got carotid ultrasound at the beginning of the study and one year after achieving euthyroid status with replacement treatment, to establish differences in the parameters evaluated before and after replacement treatment.
Results: Prior to treatment, hypercholesterolemia was found in 87.2% of patients and hypertriglyceridemia in 38.3%, while elevated LDL cholesterol and decreased HDL cholesterol values were found in 55.3% and 19. .3% of them, CIMT was within the normal range. After treatment with levothyroxine, all the mean values of the parameters studied were modified, except in the case of triglycerides.
Conclusions: Subclinical hypothyroidism replacement therapy has beneficial effects on CIMT, which could be secondary, among other factors, to the improvement of the lipid profile.


REFERENCES

  1. López Rubio MA, Tárraga López PJ, Rodríguez Montes JA, Frías López MC, Solera Albero J, Bermejo López P. Hipotiroidismo subclínico y riesgo cardiovascular. Nutr Hosp. 2015[acceso: 10/07/2019];31(5):2095-102. Disponible en: http://www.nutricionhospitalaria.com/pdf/8740.pdf

  2. Hennessey JV, Espaillat R. Subclinical hypothyroidism: a historical view and shifting prevalence. Int J Clin Pract. 2015[acceso: 09/07/2019];69(7):771-82. Disponible en: http://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.12619

  3. Yasar Yilmaz H, Demirpence M, Colak A, Yurdakul L, Zeytinli M, Turkon H, et al. Serum irisin and apelin levels and markers of atherosclerosis in patients with subclinical hypothyroidism. Arch Endocrinol Metab. 2019[acceso: 10/07/2019];63(1). Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972019000100016&lng=en

  4. Rhee SS, Pearce EN. Sistema endocrino y corazón: una revisión. Rev Esp Cardiol. 2011[acceso: 31/07/2019];64(3):220-31. Disponible en: https://www.revespcardiol.org/index.php?p=revista&tipo=pdf-simple&pii=S0300893210000813

  5. Ning Y, Cheng YJ, Liu LJ, Sara JDS, Cao ZY, Zheng WP, et al. What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1,898,314 participants. BMC Med. 2017[acceso: 05/08/2019];15(21):1-15. Disponible en: https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-017-0777-9

  6. López Rubio MA. Hipotiroidismo subclínico y factores de riesgo cardiovascular [Tesis Doctoral]. España: Universidad autónoma de Madrid; 2014[acceso: 10/07/2019]:138. Disponible en: http://repositorio.uam.es/bitstream/handle/10486/663391/lopez_rubio_maria_antonia.pdf?sequence=1

  7. Jiménez Álvarez G. Tratamiento del hipotiroidismo subclínico en la reducción de la enfermedad cardiovascular. Una síntesis narrativa de la evidencia [Tesis de grado]. Bogotá: Universidad de Ciencias Aplicadas y Ambientales; 2015[acceso: 10/07/2019]:49. Disponible en: https://repository.udca.edu.co/bitstream/handle/11158/448/TRATAMIENTO%20DEL%20HIPOTIROIDISMO%20SUBCLINICO%20EN%20LA%20REDUCCI%C3%93N%20DE.pdf?sequence=1&isAllowed=y

  8. Lu M, Yang CB, Gao L, Zhao JJ. Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (Review). Exp Ther Med. 2015[acceso: 10/07/2019];9(1):3-10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247316/pdf/etm-09-01-0003.pdf

  9. del Busto Mesa A, Cabrera Rego JO, Carrero Fernández L, Hernández Roca CV, González Valdés JL, de la Rosa Pazos. Modificaciones de la rigidez arterial, el grosor íntima-media carotideo y la grasa epicárdica con tratamiento sustitutivo en el hipotiroidismo. Endocrinol Nutr. 2015[acceso: 29/07/2019];62(6):270-6. Disponible en: https://pdfs.semanticscholar.org/ab82/f1552e5e89686af2ea28722539e2c06618bb.pdf

  10. Zhao T, Chen B, Zhou Y, Wang X, Zhang Y, Wang H, et al. Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. BMJ Open. 2017[acceso: 10/07/2019];7(10):1-10. Disponible en: https://bmjopen.bmj.com/content/bmjopen/7/10/e016053.full.pdf

  11. Saif A, Mousa S, Assem M, Tharwat N, Abdelhamid A. Endothelial dysfunction and the risk of atherosclerosis in overt and subclinical hypothyroidism. Endocr Connect. 2018[acceso: 05/05/2019];7(10):1075-80. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198186/pdf/ec-7-1075.pdf

  12. Beralkar A, Acharya S, Gagneja S, Shukia S, Kumar S, Wanjari A. Carotid intima-media thickness (C-IMT) in hypothyroidism-early assessment of subclinical atherosclerosis. J Evid Based Med Healthc. 2018[acceso: 03/08/2019];5(52):3539-44. Disponible en: https://www.researchgate.net/publication/329921590_CAROTID_INTIMA-MEDIA_THICKNESS_C-IMT_IN_HYPOTHYROIDISM-_EARLY_ASSESSMENT_OF_SUBCLINICAL_ATHEROSCLEROSIS

  13. Yao K, Zhao T, Zeng L, Yang J, Liu Y, He Q, et al. Non-invasive markers of cardiovascular risk in patients with subclinical hypothyroidism: a systematic review and meta-analysis of 27 case control studies. Sci Rep. 2018[acceso: 21/10/2020];8(1):4579. Disponible en: https://www.nature.com/articles/s41598-018-22897-3.pdf

  14. Li X, Wang Y, Guan Q, Zhao J, Gao L. The lipid-lowering effect of levothyroxine in patients with subclinical hypothyroidism: a systematic review and meta-analysis of randomized controlled trials. Clin Endocrinol. 2017[acceso: 03/08/2019];87(1):1-9. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.13338

  15. Consenso en el diagnóstico y tratamiento de las afecciones del tiroides. Rev Cuba Endocrinol. 2004[acceso: 10/07/2019];15(1). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532004000100013

  16. Ning Y, Cheng YJ, Liu LJ, Sara JDS, Cao ZY, Zheng WP, et al. What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1 898 314 participants. BMC Med. 2017[acceso: 05/08/2019];15(21):1-15. Disponible en: https://bmcmedicine.biomedcentral.com/track/pdf/10.1186/s12916-017-0777-9

  17. Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Ann Fam Med. 2004[acceso: 22/03/2021];2(4):351-5. Disponible en: https://www.annfammed.org/content/annalsfm/2/4/351.full.pdf

  18. Nikhil RA, Samir S, Kanwar JB, Subhashree R. Effect of subclinical hypothyroidism on serum lipid profile. IJAST. 2020[acceso: 23/03/2021];29(8s):2644-67. Disponible en. http://sersc.org/journals/index.php/IJAST/article/download/15180/7707

  19. Humerah S, Siddiqui A, Khan HF. Pattern of altered lipip profile in patients with subclinical and Clinical hypothyroidism and its correlation with body mass index. J Coll Physicians Surg Pak. 2016[acceso: 23/03/2021];26(6):463-6. Disponible en: https://www.jcpsp.pk/archive/2016/Jun2016/04.pdf

  20. Shahebrahimi K, Nazeri R, Kalantarian TS, Rahimi M, Najafi F, Derakhshandeh K, et al. Effects of levothyroxine treatment on lipid profile in subclinical hypothyroidism: a randomized Clinical trial. GMJ. 2015[acceso: 24/03/2021];4(2). Disponible en: https://www.gmj.ir/index.php/gmj/article/view/214/html_76

  21. Mulic M, Halo O, Skrijelj F, Mulic B. Beneficial effects of levothyroxine in the treatment of subclinical hypothyroidism. SANAMED. 2016[acceso: 25/03/2021];1(3):203-9. Disponible en: https://www.sanamed.rs/OPJ/index.php/Sanamed/article/download/130/70

  22. Saxena A, Kapoor P, Saxena S, Kapoor AK. Effect of levothyroxine therapy on dislipidemia in hypothyroidism patient. Internet J Medical Update. 2013[acceso: 23/03/2021];8(2):39-49. Disponible en: https://www.ajol.info/index.php/ijmu/article/download/93198/82611

  23. Maurya DR, Borthakur S, Nyaharkar N. Impat of levothyroxine therapy on lipid profile value in patients of subclinical hypothyroidism. J Med Sci. 2019[acceso: 23/03/2021];5(2):39-42. Disponible en: https://www.jmedsciences.com/doi/JMEDS/pdf/10.5005/jp-journals-10045-00119

  24. Pala NA, Ashraf M, Bhoughal B. Pattern of lipid alterations in subclinical hypothyroidism: response to levothyroxine replacement. Int J Med Res Rev. 2017[acceso: 25/03/2021];5(9):865-71. Disponible en: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/922

  25. Lorenz MW, Gao L, Ziegelbaur K, Norata GD, Empana JP, Schmidtmann I, et al. Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk- Results from the PROG-IMT collaboration. Plos ONE. 2018[acceso: 21/10/2020];13(4):0191172. Disponible en: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0191172&type=printable

  26. Castellano Vázquez JM. De las escalas de riesgo poblacional a la cuantificación de la aterosclerosis subclínica: hacia un nuevo paradigma en la predicción cardiovascular. Rev Esp Cardiol. 2017[acceso: 19/10/2020];70(7):532-4. Disponible en: https://www.revespcardiol.org/index.php?p=revista&tipo=pdf-simple&pii=S0300893217300246

  27. Verdugo Rosas A, Rochín Terán JL, Zataráin Bayliss L. Medición ecográfica del grosor intima media carotideo en pacientes jóvenes sanos con diferentes índices de masa corporal. Rev Med UAS. 2018[acceso: 21/10/2020];8(2):66-73. Disponible en: http://hospital.uas.edu.mx/revmeduas/pdf/v8/n2/medicionecografica.pdf

  28. Vijayan V, Jayasingh K, Jayaraman G, Green SR, Deyagarasan E. Assessment of carotid intima-media thickness in hypothyroidism and the effect of thyroid replacement therapy. IJAM. 2018[acceso: 03/03/2021];5(2):281-88. Disponible en: https://www.researchgate.net/publication/323564422_Assessment_of_carotid_intima-media_thickness_in_hypothyroidism_and_the_effect_of_thyroid_replacement_therapy

  29. Aziz M, Kandimalla Y, Machavarapu A, Saxena A, Das S, Younos A, et al. Effect of thyroxin treatment on carotid intima- media thickness (CIMT) reduction in patients with subclinical hypothyroidism (SCH): a meta-analysis of clinical trials. J Atheroscler Thromb. 2017[acceso: 21/10/2020];24(7):643-59. Disponible en: https://pdfs.semanticsholar.org/2769/3656639673d20b44b657105fe124b687af6a.pdf?ga=2.5587248.2080105984.1603304987-344604657.1593806623




2020     |     www.medigraphic.com